Izotropic Corporation
Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. The company develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses offering high resolution, true 3D dedicated breast imaging with 360-degree image acquisition and can be used with or without injectable contrast. Izotropic Corporation … Read more
Izotropic Corporation (IZOZF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of October 2025: 0.062x
Based on the latest financial reports, Izotropic Corporation (IZOZF) has a cash flow conversion efficiency ratio of 0.062x as of October 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-342.77K) by net assets ($-5.50 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Izotropic Corporation - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Izotropic Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Izotropic Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Izotropic Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Opter AB
ST:OPTER
|
0.230x |
|
LGMS Berhad
KLSE:0249
|
0.039x |
|
Earth Tech Environment Public Company Limited
BK:ETC
|
0.001x |
|
Isofol Medical AB
ST:ISOFOL
|
-0.100x |
|
Bayview Acquisition Corp Unit
NASDAQ:BAYAU
|
-0.001x |
|
Ozsu Balik Uretim A.S.
IS:OZSUB
|
0.430x |
|
3P Learning Ltd
AU:3PL
|
0.087x |
|
Principal Technologies Inc
V:PTEC
|
1.473x |
Annual Cash Flow Conversion Efficiency for Izotropic Corporation (2017–2025)
The table below shows the annual cash flow conversion efficiency of Izotropic Corporation from 2017 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-04-30 | $-4.86 Million | $-636.23K | 0.131x | -15.15% |
| 2024-04-30 | $-3.85 Million | $-593.57K | 0.154x | -85.48% |
| 2023-04-30 | $-3.07 Million | $-3.27 Million | 1.063x | -91.64% |
| 2022-04-30 | $-374.59K | $-4.76 Million | 12.718x | +1964.51% |
| 2021-04-30 | $4.52 Million | $-3.08 Million | -0.682x | +51.14% |
| 2020-04-30 | $707.22K | $-987.43K | -1.396x | +0.05% |
| 2019-04-30 | $316.84K | $-442.61K | -1.397x | +5.83% |
| 2018-04-30 | $407.76K | $-604.88K | -1.483x | -273.93% |
| 2017-04-30 | $-64.67K | $-55.16K | 0.853x | -- |